LONDON, July 28 — A new drug developed at the University of Sheffield could become available to patients diagnosed with a wide range of cancers, the...
LONDON — The board of AstraZeneca on Monday rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, a decision that caused a sharp slide...